September 8, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and Carterra Initiate a Clinical Research Collaboration for COVID-19 Variant Analysis

SEPTEMBER 08, 2021 Companies bring together cutting-edge technologies and expertise to advance the world’s understanding of COVID-19 variants’ mechanism of action MINNEAPOLIS and SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ — Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in... Read more

September 7, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Sep 7, 2021 SAN DIEGO, Sept. 7, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for... Read more

September 1, 2021 Life Science Tools Product Launch

SCIEX presents industry first multi-capillary system for CE-SDS, the BioPhase 8800 system

Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, presents the latest capillary electrophoresis solution, the BioPhase 8800 system. This is the only... Read more

September 1, 2021 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics

Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics CARLSBAD, Calif., Sept. 1, 2021 /PRNewswire/ — Thermo Fisher Scientific’s clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca’s expanding portfolio of targeted therapies. The companies will collaborate under a multiyear, global agreement. “As the... Read more

August 25, 2021 Acad, Gov/Utilities Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 Life Science Tools

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif., Aug. 25, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to... Read more

August 9, 2021 Life Science Tools

GE Healthcare Brings Radiology Without Walls to Resource-Constrained Small Imaging Centers With AI-Enabled, Cloud Imaging Solution

GE Healthcare Brings Radiology Without Walls to Resource-Constrained Small Imaging Centers With AI-Enabled, Cloud Imaging Solution ·       Edison True PACS[1] is a transformative system, offering AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity, and improve diagnostic accuracy ·       Innovative, cloud-based system removes barriers to adopting new diagnostic radiology efficiency... Read more

August 3, 2021 Life Science Tools PR/Corporate

Agilent Announces Target Enrichment Manufacturing Facility in China

Customers will benefit from reduced delivery time for next generation sequencing (NGS) products  SANTA CLARA, Calif., August 03, 2021  Agilent Technologies Inc. (NYSE: A) today announced that it has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China. Agilent is a leading provider of next-generation sequencing assays, and customers often develop... Read more

August 2, 2021 Life Science Tools M&A, Partnerships

Rigaku Acquires Life Science Imaging Equipment Manufacturer MILabs

Full-Scale Entry into the Global Life Sciences Business Rigaku Corporation (Headquarters: Akishima-shi, Tokyo; President: Toshiyuki Ikeda; “Rigaku”), a leading manufacturer of X-ray analysis equipment, has acquired all issued shares of MILabs B.V. (Headquarters: Houten, The Netherlands; CEO and CSO: Dr. Frederik Beekman; “MILabs”) on August 2, 2021, as part of their full-scale effort to enter... Read more

August 2, 2021 Life Science Tools M&A, Partnerships

Abcam to acquire BioVision for $340 million

2 August 2021, Cambridge, UK  – Abcam plc (“Abcam”, “the Company” or “the Group”) (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that it has entered into a definitive agreement to acquire BioVision, Inc. (“BioVision”), a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (“NKY”), for... Read more